DEPLOYDatabase

Robot model

PRIMA BCI

biometricpilotby Science Corp

Biohybrid retinal implant brain-computer interface designed to restore vision.

Track PRIMA BCI
Manufacturer
Science Corp
Form factor
biometric
Maturity
pilot
Lifecycle
active
Deployments
2

Overview

Biohybrid retinal implant brain-computer interface designed to restore vision. In clinical trials. It is a biometric system designed for physical AI applications. Key specifications include Form Factor: biometric, Maturity: pilot.

Verified vs. claimed

Maturity stage
pilot(Small-scale deployment in controlled or trial conditions.)
Sources on file
View all sources →

Key facts

Series C (company-stated, Mar 2026)

Closed a $230 million Series C on 5 March 2026 to commercialize PRIMA, led by Khosla Ventures, Lightspeed, Y Combinator, IQT and Quiet Capital.

Capital raised (company-stated)

About $490 million invested since Science's 2021 founding.

Trial result (company-stated)

In a European trial of 38 people with advanced dry AMD, published in NEJM, 80 percent had a meaningful visual-acuity gain.

Regulatory filings (company-stated)

Science has submitted a CE mark application and applied to the FDA.

Data & sources

Web sources

1

1 source backing this record.View all →

Pricing

No verified price is on record for PRIMA BCI. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Deployments (2)

PRIMA BCI on the deployment map

View the global map

Where PRIMA BCI is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for PRIMA BCI.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (1)

  1. https://science.xyz/news/series-c/

Mentioned on (1)

Registry pages whose text names PRIMA BCI.

Companies (1)

Science Corp

Common questions

What is PRIMA BCI?
Biohybrid retinal implant brain-computer interface designed to restore vision. In clinical trials. It is a biometric system designed for physical AI applications. Key specifications include Form Factor: biometric, Maturity: pilot.
How much does PRIMA BCI cost?
PRIMA BCI's price is not publicly disclosed. DEPLOY has no verified price on record for PRIMA BCI from Science Corp. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is PRIMA BCI actually deployed in the real world?
Yes. PRIMA BCI is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes PRIMA BCI?
PRIMA BCI is made by Science Corp, based in Alameda, California, USA, founded in 2021.
Where is PRIMA BCI deployed?
2 verified deployments of PRIMA BCI are on the DEPLOY registry, including at Germany, Europe, United States.
Can you buy PRIMA BCI?
PRIMA BCI is in pilot deployments with named customers and is not yet broadly for sale.
What are alternatives to PRIMA BCI?
On the DEPLOY registry, comparable biometric robots to PRIMA BCI include Blackrock Neuroport Array, Synchron Stentrode, BrainQ Non-Invasive BCI, Neko Body Scan.
How does PRIMA BCI compare to Blackrock Neuroport Array?
PRIMA BCI and Blackrock Neuroport Array (Blackrock Neurotech · 5 deployments) are both biometric robots on the DEPLOY registry. PRIMA BCI has 2 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is PRIMA BCI a top biometric?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, PRIMA BCI ranks in roughly the top 52% of biometric models tracked by the registry.
What is PRIMA BCI's maturity stage?
PRIMA BCI is at the pilot stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Pilot stage means at least one named-customer trial deployment is verified.
Is PRIMA BCI safe?
PRIMA BCI has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-10-10

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-10-10

Maturity + lifecycle

Maturity stage: pilot

Lifecycle: active

Architectural position

Cohort: biometric

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for PRIMA BCI.

Recent coverage

PRIMA BCI in third-party press

Digital Health Roundup: CE Mark For Vision-Restoring Implant, AI Chatbot Rules, MS Deal

Aug 6, 2026

Science Corp. Announces European Commercial Launch of PRIMA, the Only Treatment to Restore Functional Central Vision to Patients with Geographic Atrophy Caused by Age-Related Macular Degeneration, a Leading Cause of Blindness

Jul 22, 2026

Science gains CE mark; Ability, Precision show BCI capabilities

Jul 22, 2026